Related Experiment Video
Updated: Jul 2, 2026
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Targeting the MDM2-p53 interaction for cancer therapy
Sanjeev Shangary1, Shaomeng Wang
1Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109-0934, USA.
Summary
Reactivating the tumor suppressor p53 protein, often inhibited by MDM2 in cancer, is a promising therapeutic strategy. This review covers advances in small-molecule inhibitors targeting the MDM2-p53 interaction for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- The p53 protein is a critical tumor suppressor, crucial for preventing cancer development.
- p53 function is compromised in approximately half of human cancers due to gene mutation or deletion.
- In cancers with intact p53, its activity is suppressed by the MDM2 oncoprotein.
Purpose of the Study:
- To review the progress in developing small-molecule inhibitors that target the MDM2-p53 interaction.
- To explore the therapeutic potential of reactivating p53 for cancer treatment.
Main Methods:
- Literature review of studies on MDM2-p53 interaction inhibitors.
- Analysis of small-molecule inhibitor design and development strategies.
Main Results:
- Small-molecule inhibitors targeting the MDM2-p53 interaction have shown promise in preclinical studies.
- These inhibitors aim to restore the tumor-suppressive functions of wild-type p53.
Conclusions:
- Blocking the MDM2-p53 interaction is a viable strategy for cancer therapy.
- Further development of these inhibitors could lead to novel cancer treatments.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...